New ONCE-DAILY Repliva 21/7™ Tablets
 
 
 
Important Repliva 21/7™
Information


Footnote References
Prescribing Information
Safety Information
 
Pharmacist information
Repliva 21/7 Tablets are prescription oral iron supplements 
delivering improved absorption, bioavailability, and tolerance 
vs older iron treatments. (1) Repliva 21/7 is a “sole source” 
product and there are no products with the same active 
ingredients in the same amount as ONCE-DAILY REPLIVA 21/7.
21 active tablets/7 placebo tablets
NDC# 64011-165-34
Three 28-day supply per trade box
 
WARNING: Hemochromatosis and hemosiderosis are contraindications to iron therapy. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Home  |  Search  |  Contact Us  |  Site Directory  |  Safety Information  |  Prescribing Information  |  Ther-Rx & Women's Healthcare


©2008 Ther-Rx Corporation Terms of Use of Site